信息搜索
信息关键字:药
 

共有5342条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263] [264] [265] [266] [267] [268]

·京新药业实际控制人计划增持不超过736万股2018-1-23 12:37:41
·红日药业控股股东质押8700万股2018-1-23 12:04:07
·交易提示:风神股份、九洲药业临时停牌2018-1-23 9:29:45
·千山药机定增生变“补血”升级业务模式计划泡汤2018-1-23 8:01:53
·药企海外并购今年或升温2018-1-23 6:50:56
·上市2月涨11倍药石科技百亿市值进阶2018-1-23 5:52:38
·康美药业主体信用评级上调至AAA2018-1-22 23:23:16
·合全药业要做市了,成集合竞价以来首家转做市公司2018-1-22 21:14:42
·合全药业拟自1月24日起转做市2018-1-22 19:38:40
·康泰生物收到《药物临床试验批件》2018-1-22 19:05:08
·医药生物行业:紧抓龙头创新药放量进入新时代(附股)2018-1-22 11:15:23
·医药生物行业:紧抓龙头创新药放量进入新时代(附股)2018-1-22 11:15:07
·华润赛科拟1.4亿元转让新赛科药业51%股权2018-1-22 7:40:33
·九洲药业控股股东提议10转8并派现金2018-1-22 7:36:22
·广誉远董事长张斌:全产业链模式打造精品中药2018-1-22 3:09:05
·海正药业信息披露自相矛盾子公司增资一事遭三度问询2018-1-22 2:54:10
·公告精选:九洲药业推高送转预案;多家公司年报业绩大幅预增2018-1-21 23:56:29
·公告精选:九洲药业推高送转预案贝因美2017年净利预亏8至10亿2018-1-21 21:29:48
·九洲药业1亿元发起设立医药基金2018-1-21 20:36:13
·九洲药业:年报拟10转8并派现2018-1-21 18:23:37

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263] [264] [265] [266] [267] [268]